Inferring tumour purity and stromal and immune cell admixture from expression data
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and not only perturb the tumour signal in molecular studies but also have an important role in cancer biology. Here we describe ‘Estimation of STromal and Immune cells in MAlignant Tumours using Expression data’ (ESTIMATE)—a method that uses gene expression signatures to infer the fraction of stromal and immune cells in tumour samples. ESTIMATE scores correlate with DNA copy number-based tumour purity across samples from 11 different tumour types, profiled on Agilent, Affymetrix platforms or based on RNA sequencing and available through The Cancer Genome Atlas. The prediction accuracy is further corroborated using 3,809 transcriptional profiles available elsewhere in the public domain. The ESTIMATE method allows consideration of tumour-associated normal cells in genomic and transcriptomic studies. An R-library is available on https://sourceforge.net/projects/estimateproject/ . Tumour biopsies contain contaminating normal cells and these can influence the analysis of tumour samples. In this study, Yoshihara et al.develop an algorithm based on gene expression profiles from The Cancer Genome Atlas to estimate the number of contaminating normal cells in tumour samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“this result is not merely a reflection of the extent of immune infiltration, as indicated by the lack of correlation between the γδ T cell signature score and ESTIMATE (Yoshihara et al., 2013) immune signature score for individual patients”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Yoshihara et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 2×
“We devised two gene signatures: (1) a ‘stromal signature’ that was designed to capture the presence of stroma in tumour tissue, and (2) an ‘immune signature’ that aimed to represent the infiltration of immune cells in tumour tissue (Supplementary Data 1).”
MethodRSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Cited by
Items 401–500 of 1,021
Lu, L., Liu, L., Zhao, Q., Gui, R., & Zhao, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.675545 · Cited by 105
“Immunogenomic Landscape Analyses Computational methods were used to evaluate the immune infiltration and functions, including ESTIMATE (32), TIMER (33), MCP-counter (34), CIBERSORTx (35), and single-sample gene set enrichment analysis (ssGSEA) in an attempt to comprehensively analyze the immune differences between the…”
MethodInfluentialSoltis, A. R., Bateman, N. W., Liu, J., Nguyen, T. M., Franks, T. J., Zhang, X., Dalgard, C. L., Viollet, C., Somiari, S., Yan, C., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100819 · Cited by 93
Chen, X., Yan, B., Lou, H., Shen, Z., Tong, F., Zhai, A., Wei, L., & Zhang, F. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.02.005 · Cited by 90
Hu, Q., Lei, T., Hu, Y., & Lei, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673827 · Cited by 97
Ke, M. S., Elshenawy, B., Sheldon, H., Arora, A., & Buffa, F. M. (2022) · BioEssays · doi:10.1002/bies.202200084 · Cited by 89
“ulations of cells whichmight be crucial to understanding tumour origin and progression.[1,2] To address this problem, bulk RNA-Seq has been combined with technologies such as fluorescence-activated cell sorting (FACS) to sort cells of different types, and identify the expression of”
MethodZhang, H., Zhang, N., Wu, W., Zhou, R., Li, S., Wang, Z., Dai, Z., Zhang, L., Liu, Z., Zhang, J., et al. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac386 · Cited by 93
de la Rocha, A. A., Berlow, N., Fader, M. E., Coats, E. R., Saghira, C., Espinal, P. S., Galano, J., Khatib, Z. A., Abdella, H., Maher, O. M., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02848-4 · Cited by 91
Bray, S. M., Lee, J., Kim, S. T., Hur, J. Y., Ebert, P. J., Calley, J. N., Wulur, I. H., Gopalappa, T., Wong, S. S., Qian, H.-R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51981-5 · Cited by 82
Self-citationXu, M., Li, Y., Li, W., Zhao, Q., Zhang, Q., Le, K., Huang, Z., & Yi, P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00064 · Cited by 89
“Based on the univariate analysis, we include immune score in next multivariate analysis but stromal score and ESTIMATE score were excluded since these scores were linearly dependent on each other as shown in Supplementary Figure S4.”
MethodInfluentialTang, B., Yan, R., Zhu, J., Cheng, S., Kong, C., Chen, W., Fang, S., Wang, Y., Yang, Y., Qiu, R., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.64654 · Cited by 87
“cell invasion) based on the expression of immune genes in the sample [37].”
BackgroundMethodESR1 mutant breast cancers show elevated basal cytokeratins and immune activation
Li, Z., McGinn, O., Wu, Y. F., Bahreini, A., Priedigkeit, N., Ding, K., Onkar, S., Lampenfeld, C., Sartorius, C. A., Miller, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29498-9 · Cited by 85
A multimodal atlas of tumour metabolism reveals the architecture of gene–metabolite covariation
Benedetti, E., Liu, E. M., Tang, C., Kuo, F., Büyüközkan, M., Park, T., Park, J., Correa, F., Hakimi, A. A., Intlekofer, A. M., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00817-8 · Cited by 83
Cheng, Y., Chen, X., Li, F., Yang, Z., Xiao, L., Xiang, B., Wang, X., Liu, D., Lin, P., Shi, J.-Y., et al. (2025) · Cell Discovery · doi:10.1038/s41421-024-00747-z · Cited by 85
Xu, Y., Zhao, W., Xu, J., Li, J., Hong, Z., Yin, Z., & Wang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.6839 · Cited by 81
“Infiltrating stromal and immune cells in the tumor microenvironment contribute to cancer biology as well [3].”
Dijk, F., Veenstra, V. L., Soer, E. C., Dings, M. P. G., Zhao, L., Halfwerk, J. B. G., Hooijer, G. K. J., Damhofer, H., Marzano, M., Steins, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-56826-9 · Cited by 94
de Cubas, A. A., Dunker, W., Zaninovich, A., Hongo, R. A., Bhatia, A., Panda, A., Beckermann, K. E., Bhanot, G., Ganesan, S., Karijolich, J. J., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137569 · Cited by 84
“ESTIMATE Immune Score as a surrogate for immune infiltration (29).”
BackgroundMethodWang, Z., Su, G.-H., Dai, Z., Meng, M., Zhang, H., Fan, F., Liu, Z., Zhang, L., Weygant, N., He, F., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.12988 · Cited by 87
B2M overexpression correlates with malignancy and immune signatures in human gliomas
Zhang, H., Cui, B., Zhou, Y., Wang, X., Wu, W., Wang, Z., Dai, Z., Cheng, Q., & Yang, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-84465-6 · Cited by 87
Du, M., Gu, D., Xin, J., Peters, U., Song, M., Cai, G., Li, S., Ben, S., Meng, Y., Chu, H., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100974 · Cited by 95
“ESTIMATE Yoshihara et al.(61) https://bioinformatics.”
MethodInfluentialLouault, K., Bonneaud, T. L., Séveno, C., Gomez‐Bougie, P., Nguyen, F., Gautier, F., Bourgeois, N., Loussouarn, D., Kerdraon, O., Barillé‐Nion, S., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0635-z · Cited by 85
Qu, Y., Cheng, B., Shao, N., Jia, Y., Song, Q., Tan, B., & Wang, J. (2020) · Aging · doi:10.18632/aging.102871 · Cited by 90
“…gene expression signatures of immune and stromal cells, Yoshihara et al. created an algorithm called ESTIMATE (Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data) to calculate immune and stromal scores for predicting the infiltration of non-tumor cells [20].”
Pan-Cancer Analysis of Ligand–Receptor Cross-talk in the Tumor Microenvironment
Ghoshdastider, U., Rohatgi, N., Naeini, M. M., Baruah, P., Revkov, E., Guo, Y. A., Rizzetto, S., Wong, A. M. L., Solai, S., Nguyen, T. T., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2352 · Cited by 94
“Similarly, we found that previously derived stromal and immune-cell–specific gene sets (12) were inferred to have markedly higher expression in the stroma compartment of all tumor types (Fig.”
BackgroundResultLin, D., Fan, W., Zhang, R., Zhao, E., Li, P., Zhou, W., Peng, J., & Li, L. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02952-w · Cited by 93
“Additionally, ESTIMATE algorithm was used to compute the stromal score, immune score, ESTIMATE score, and tumor purity for each tumor sample [25].”
MethodRen, Z., Hu, M., Wang, Z., Ge, J., Zhou, X., Zhang, G., & Zheng, H. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.672904 · Cited by 91
Wu, C.-C., Wang, Y., Livingston, J. A., Zhang, J., & Futreal, P. A. (2022) · Nature Communications · doi:10.1038/s41467-021-27651-4 · Cited by 86
Chen, L., Niu, X., Qiao, X., Liu, S., Ma, H., Shi, X., He, X., & Zhong, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.739039 · Cited by 97
“Estimation of TumorMicroenvironment (TME) Estimation of STromal and Immune cells in MAlignant Tumours usingExpression data (ESTIMATE)may infer the tumor cellularity and tumor purity based on unique properties of the transcriptional profiles (29).”
BackgroundKhouzam, R. A., Zaarour, R. F., Brodaczewska, K. K., Azakir, B., Venkatesh, G. H., Thiery, J., Terry, S., & Chouaïb, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.828875 · Cited by 85
Yadav, V. K., & De, S. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbu002 · Cited by 91
Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma
Yue, C., Ma, H., & Zhou, Y. (2019) · PeerJ · doi:10.7717/peerj.8128 · Cited by 93
“…algorithm was used to calculate corresponding immune scores, stromal scores and tumor purities Yue et al. (2019), PeerJ, DOI 10.7717/peerj.8128 4/16 (Yoshihara et al., 2013), and the difference of tumor purities, expression of HLA genes between high-risk and low-risk samples was further analyzed.”
BackgroundMethodInfluentialMeng, Z., Ren, D., Zhang, K., Zhao, J., Jin, X., & Wu, H. (2020) · Aging · doi:10.18632/aging.102931 · Cited by 79
Liu, D., Shoag, J. E., Poliak, D., Goueli, R. S., Ravikumar, V., Redmond, D., Vosoughi, A., Fontugne, J., Pan, H., Lee, D. C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15913-6 · Cited by 85
Zeng, H., Ji, J., Song, X., Huang, Y., Li, H., Huang, J., & Ma, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.549213 · Cited by 86
“Inference of Infiltrating Cells in TME The ESTIMATE algorithm (Yoshihara et al., 2013) was applied to explore the immune function of SRGs in term of immune responses.”
MethodImmune response drives outcomes in prostate cancer: implications for immunotherapy
Meng, J., Zhou, Y., Lu, X., Bian, Z., Chen, Y., Fan, S., Zhou, J., Zhang, L., 郝宗耀, Zhang, M., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12887 · Cited by 87
Proteogenomics of glioblastoma associates molecular patterns with survival
Arad, G., Ofek, P., Yeini, E., Mardamshina, M., Danilevsky, A., Shomron, N., Grossman, R., Satchi‐Fainaro, R., & Geiger, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108787 · Cited by 81
Liu, J., Chen, C., Wang, Y., Qian, C., Wei, J., Xing, Y., & Bai, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746647 · Cited by 96
“ESTIMATE algorithm was utilized to score stromal and immune gene sets and calculate tumor purity (40).”
MethodWang, T., Dai, L., Shen, S. Y., Yang, Y., Yang, M., Yang, X., Qiu, Y., & Wang, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843408 · Cited by 91
“Immunogenomic Landscape Analysis In order to investigate the difference in the TME among macrophage-related clusters, the stromal score, immune score, estimate score, and tumor purity were estimated using the “ESTIMATE” R package based on the results of single-sample gene set enrichment analysis (ssGSEA) (21).”
MethodA Comprehensive Overview of RNA Deconvolution Methods and Their Application
Im, Y., & Kim, Y. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.2178 · Cited by 94
“However, enrichment-based approaches and probabilistic approaches often come with a limit in the number of cell types that can be used (e.g., both 2 cell types for ESTIMATE [Yoshihara et al., 2013] and ISOpure [Quon et al., 2013]), with exception of xCell (Aran et al., 2017).”
Zhao, S., Chen, D.-P., Fu, T., Yang, J., Ma, D., Zhu, X.-Z., Wang, X.-X., Jiao, Y., Jin, X., Xiao, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42504-y · Cited by 94
“The ESTIMATE stromal score and xCell stromal score were calculated to estimate the overall abundance of stroma cells 73,74 .”
Computational immunogenomic approaches to predict response to cancer immunotherapies
Addala, V., Newell, F., Pearson, J. V., Redwood, A., Robinson, B. W. S., Creaney, J., & Waddell, N. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00830-6 · Cited by 86
“Various computational approaches have been developed to measure tumour purity from DNA-seq 34–36 and RNA-seq 37,38 , or DNA methylation profiling 33 data, as well as integrated consensus approaches 33 (Fig.”
Measuring intratumor heterogeneity by network entropy using RNA-seq data
Park, Y., Lim, S., Nam, J., & Kim, S. (2016) · Scientific Reports · doi:10.1038/srep37767 · Cited by 89
“For tumor purity information, we used three scores– stromal score, immune score, and tumor purity score– by ESTIMATE in 1,557 patients across 8 different cancer types 60 .”
MethodTumor diversity and the trade-off between universal cancer tasks
Hausser, J., Székely, P., Bar, N., Zimmer, A., Sheftel, H., Caldas, C., & Alon, U. (2019) · Nature Communications · doi:10.1038/s41467-019-13195-1 · Cited by 87
Immune gene expression profiling reveals heterogeneity in luminal breast tumors
Zhu, B., Tse, L. A., Wang, D., Koka, H., Zhang, T., Abubakar, M., Lee, P. M. Y., Wang, F., Wu, Ç., Tsang, K. H., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1218-9 · Cited by 91
“Adjusting for tumor purity, which was inferred using ESTIMATE purity score, did not significantly change the results (Supplementary Figure 2).”
MethodInfluentialIdentification of Distinct Immune Subtypes in Colorectal Cancer Based on the Stromal Compartment
Shen, R., Li, P., Li, B., Zhang, B., Feng, L., & Cheng, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01497 · Cited by 114
“The tumor purity information of the TCGA-COADREAD and GSE39582 cohorts was extracted from previous TCGA research (25) using the ABSOLUTE method (26) and estimated using the R package “estimate” (27).”
MethodWu, X., Qu, D., Weygant, N., Peng, J., & Houchen, C. W. (2020) · Cancers · doi:10.3390/cancers12020274 · Cited by 83
“The stromal and immune scores were calculated using the ESTIMATE packages in R [90,91].”
MethodPereira, B., Chen, C. T., Goyal, L., Walmsley, C. S., Pinto, C. J., Baiev, I., Allen, R., Henderson, L. E., Saha, S. K., Reyes, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23394-4 · Cited by 82
Guo, J., Chen, D., Deng, S.-H., Huang, J.-R., Song, J., Li, X.-Y., Cui, B., & Liu, Y. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03076-2 · Cited by 85
Parker, A. L., Bowman, E. D., Zingone, A., Ryan, B. M., Cooper, W. A., Kohonen‐Corish, M. R. J., Harris, C. C., & Cox, T. R. (2022) · Genome Medicine · doi:10.1186/s13073-022-01127-6 · Cited by 81
“In silico estimation of tumor purity using ESTIMATE [61] revealed significantly lower tumor purity in the ECM-High matreotype compared with the ECM-Low matreotype (Fig.”
InfluentialHarnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
Gu, Y., Zhang, Z., & ten Dijke, P. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-00980-8 · Cited by 80
“For example, contamination by stromal cells increases the mesenchymal score [103, 104].”
BackgroundPang, L., Dunterman, M., Guo, S., Khan, F., Liu, Y., Taefi, E., Bahrami, A., Geula, C., Hsu, W.-H., Horbinski, C., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01605-y · Cited by 80
Xie, J., Deng, X., Xie, Y., Zhu, H., Liu, P., Deng, W., Ning, L., Tang, Y., Sun, Y., Tang, H., et al. (2024) · MedComm · doi:10.1002/mco2.502 · Cited by 94
“Moreover, the ESTIMATE algorithm was used to infer the overall stromal and immune infiltration levels, 33 and the findings were broadly consistent with the above (Figure 4B).”
MethodLiu, H., Gao, J.-W., Feng, M., Cheng, J., Tang, Y., Cao, Q., Zhao, Z., Meng, Z., Zhang, J., Zhang, G., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.012 · Cited by 87
Chen, Y., Sun, Z., Chen, W., Liu, C., Chai, R., Ding, J., Liu, W., Feng, X., Zhou, J. W., Shen, X., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.685992 · Cited by 84
Zheng, H., Liu, H., Li, H., Dou, W., & Wang, X. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.744677 · Cited by 83
“…performed on the final hub genes to identify the biological functions (including biological processes (BPs), molecular functions (MFs), and cellular components (CCs)) and pathways through clusterProfiler R package (version 3.14.3) (Yu et al., 2012). p < 0.05 was considered statistically enriched.”
BackgroundInfluentialModeling epigenetic lesions that cause gliomas
Rahme, G. J., Javed, N. M., Puorro, K. L., Xin, S., Hovestadt, V., Johnstone, S. E., & Bernstein, B. (2023) · Cell · doi:10.1016/j.cell.2023.06.022 · Cited by 79
Abba, M. C., Zhong, Y., Lee, J., Kil, H., Lu, Y., Takata, Y., Simper, M., Gaddis, S., Shen, J., & Aldaz, C. M. (2016) · Oncotarget · doi:10.18632/oncotarget.11733 · Cited by 89
“In addition, we used the ESTIMATE algorithm (Estimation of STromal and Immune cells in Malignant Tumors using Expression data) to infer the immune and stromal components from each tumor sample [39].”
MethodComprehensive assessment of cellular senescence in the tumor microenvironment
Wang, X., Ma, L., Pei, X., Wang, H., Tang, X., Pei, J.-F., Ding, Y.-N., Qu, S., Wei, Z.-Y., Wang, H.-Y., et al. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac118 · Cited by 76
“To investigate the impact of senescence on tumor immunity, we applied the Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE) algorithm [40] to evaluate the immune scores (the proportion of immune cells), stromal score (the proportion of stromal cells) and ESTIMATE score…”
Robinson, J. L., Feizi, A., Uhlén, M., & Nielsen, J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.025 · Cited by 88
“, 2015), which calculated and combined purity scores using four different methods (ESTIMATE (Yoshihara et al., 2013), ABSOLUTE (Carter et al.”
MethodJiang, W., Zhu, D., Wang, C., & Zhu, Y. (2020) · Cancer Medicine · doi:10.1002/cam4.2942 · Cited by 83
Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
Bergholtz, H., Lien, T. G., Swanson, D. M., Frigessi, A., Bathen, T. F., Borgen, E., Børresen‐Dale, A., Engebråten, O., Garred, Ø., Geisler, J., et al. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-0167-x · Cited by 76
Shi, R., Wang, X., Wu, Y. F., Xu, B., Zhao, T., Trapp, C., Wang, X., Unger, K., Zhou, C., Lu, S., et al. (2022) · Theranostics · doi:10.2139/ssrn.4062750 · Cited by 84
Ahn, B., Moon, D., Kim, H.-S., Lee, C., Cho, N. H., Choi, H., Kim, D., Lee, J.-Y., Nam, E. J., Won, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48667-6 · Cited by 85
Self-citationMolecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
Sjödahl, G., Eriksson, P., Patschan, O., Marzouka, N., Jakobsson, L., Bernardo, C., Lövgren, K., Chebil, G., Zwarthoff, E. C., Liedberg, F., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32737 · Cited by 80
Seo, J., Kim, A., Shin, J.-Y., & Kim, Y. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-32855-8 · Cited by 79
Kim, K., Jeon, S., Kim, T., & Jung, C. K. (2018) · Cancers · doi:10.3390/cancers10120494 · Cited by 82
“TCRs) [18], expression-based estimates of immune cells and stromal cells [23], and expression levels of immune checkpoints of PD-L1 and CTLA-4, as shown in Figure 2a.”
BackgroundMethodMolecular profiling of long-term IDH-wildtype glioblastoma survivors
Burgenske, D. M., Yang, J., Decker, P. A., Kollmeyer, T. M., Kosel, M., Mladek, A. C., Caron, A. A., Vaubel, R. A., Gupta, S. K., Kitange, G. J., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz129 · Cited by 77
Deciphering Immune-Associated Genes to Predict Survival in Clear Cell Renal Cell Cancer
Hu, D., Zhou, M., & Zhu, X. (2019) · BioMed Research International · doi:10.1155/2019/2506843 · Cited by 86
“evaluate the role of infiltrating stromal and immune cells in cancer biology, an algorithm called Estimation of STromal and Immune cells in MAlignant Tumours using Expression data (ESTIMATE) was raised and triggered a few genomic investigations on tumor-associated normal cells [8].”
BackgroundMethodInfluentialYin, W., Zhu, H., Tan, J., Xin, Z., Zhou, Q., Cao, Y., Wu, Z., Wang, L., Zhao, M. F., Jiang, X., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01982-0 · Cited by 75
“Analysis of immune infiltration characteristics ESTIMATE (Estimation of STromal and Immune cells in MAlignant Tumors using Expression data) is a method that uses gene expression profile to infer the fraction of stromal and immune cells in tumor samples [21].”
MethodFerroptosis‐related gene NOX4, CHAC1 and HIF1A are valid biomarkers for stomach adenocarcinoma
Xiao, R., Wang, S., Guo, J., Liu, S., Ding, A., Wang, G., Li, W., Zhang, Y., Bian, X., Zhao, S., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17171 · Cited by 83
Zhao, J. J., Ong, C. J., Srivastava, S., Chia, D. K. A., Ma, H., Huang, K. K., Sheng, T., Ramnarayanan, K., Ong, X., Tay, S. T., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.08.007 · Cited by 81
Lee, W.-C., Diao, L., Wang, J., Zhang, J., Roarty, E. B., Varghese, S., Chow, C.-W. B., Fujimoto, J., Behrens, C., Cascone, T., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0029-3 · Cited by 80
“To understand the impact of tumor microenvironment on gene expression intra-tumor heterogeneity, we inferred the proportions of infiltrating stromal and immune cells for each tumor region using a gene expression-based algorithm ESTIMATE [22] and correlated tumor microenvironment scores with the gene expression signatu…”
MethodInfluentialXu, F., Chen, J., Yang, X.-B., Hong, X.-B., Li, Z., Lin, L., & Chen, Y. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.021 · Cited by 88
“Immune score and stromal score were evaluated by applying the ESTIMATE algorithm to the gene expression data from TCGA.38,39 Tumor purity was obtained based on the ESTIMATE score using a fitted formula as previously described.39”
MethodInfluentialRuan, H., Zhou, Y., Shen, J., Zhai, Y., Xu, Y., Pi, L., Huang, R., Chen, K., Li, X., Ma, W., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.246 · Cited by 74
“The ImmuneScore was computed based on Estimation of STromal and Immune cells in MAlignant Tumors using Expression data (ESTIMATE) R package.23”
BackgroundMethodInfluentialDeep learning tackles single-cell analysis—a survey of deep learning for scRNA-seq analysis
Flores, M. A., Liu, Z., Zhang, T., Hasib, M. M., Chiu, Y., Ye, Z., Paniagua, K., Jo, S., Zhang, J., Gao, S., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab531 · Cited by 79
Zhang, N., Zhang, H., Liu, Z., Dai, Z., Wu, W., Zhou, R., Li, S., Wang, Z., Liang, X., Wen, J., et al. (2023) · Cell Proliferation · doi:10.1111/cpr.13409 · Cited by 81
Robertson, A. G., Meghani, K. A., Cooley, L. F., McLaughlin, K. A., Fall, L. A., Yu, Y., Castro, M. A. A., Groeneveld, C. S., de Reyniès, A., Nazarov, V. I., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37568-9 · Cited by 76
“To calculate ESTIMATE ImmuneScores for the PURE01 n =82 cohort, we log2-transformed the FPKMs for protein-coding genes and ran ESTIMATE v1.”
InfluentialMulti-scale signaling and tumor evolution in high-grade gliomas
Liu, J., Cao, S., Imbach, K. J., Gritsenko, M. A., Lih, T. M., Kyle, J. E., Yaron-Barir, T. M., Binder, Z. A., Li, Y., Strunilin, I., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.06.004 · Cited by 81
Li, X., Gao, Y., Xu, Z., Zhang, Z., Zheng, Y., & Qi, F. (2019) · Cancer Medicine · doi:10.1002/cam4.2774 · Cited by 83
Hu, B., Yang, X., & Sang, X. (2020) · Cancer Medicine · doi:10.1002/cam4.3353 · Cited by 73
Zhu, C., Ho, Y.-J., Salomao, M. A., Dapito, D. H., Bartolomé, A., Schwabe, R. F., Lee, J., Lowe, S. W., & Pajvani, U. B. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.032 · Cited by 76
Fisher, M. J., Jones, D., Li, Y., Guo, X., Sonawane, P., Waanders, A. J., Phillips, J. J., Weiss, W. A., Resnick, A. C., Gosline, S. J. C., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02276-5 · Cited by 73
Szabó, P. M., Vajdi, A., Kumar, N., Tolstorukov, M. Y., Chen, B. J., Edwards, R. H., Ligon, K. L., Chasalow, S. D., Chow, K.-H., Shetty, A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-28480-9 · Cited by 79
OpenPBTA: The Open Pediatric Brain Tumor Atlas
Shapiro, J. A., Gaonkar, K. S., Spielman, S. J., Savonen, C., Bethell, C. J., Jin, R., Rathi, K. S., Zhu, Y., Egolf, L. E., Farrow, B., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100340 · Cited by 87
John, M., Helal, M., Duell, J., Mattavelli, G., Stanojkovska, E., Afrin, N., Leipold, A. M., Steinhardt, M., Zhou, X., Žihala, D., et al. (2024) · Blood · doi:10.1182/blood.2024024590 · Cited by 83
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC
Fiorini, E., Malinova, A., Schreyer, D., Pasini, D., Bevere, M., Alessio, G., Rosa, D., D’Agosto, S. L., Azzolin, L., Milite, S., et al. (2025) · Nature · doi:10.1038/s41586-025-08721-9 · Cited by 82
“The ESTIMATE (estimation of stromal and immune cells in malignant tumour tissues using expression data) tool was used to infer tumour purity of a subset of tumours from the ICGC ( n = 50) and PDOs ( n = 14) as previously described 62 .”
The association between copy number aberration, DNA methylation and gene expression in tumor samples
Sun, W., Bunn, P., Jin, C., Little, P., Zhabotynsky, V., Perou, C. M., Hayes, D. N., Chen, M., & Lin, D.-Y. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky131 · Cited by 81
“gene expression and DNA methylation in tumor samples (29,30).”
BackgroundKamal, Y., Schmit, S. L., Hoehn, H. J., Amos, C. I., & Frost, H. R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3945 · Cited by 73
“To evaluate the potential influence of tumor purity, we inferred tumor purity for all samples in both datasets using the ESTIMATE algorithm (27), which uses gene expression signatures to infer fractions of stromal, immune, and cancer cells from a mixture.”
MethodCooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
Musa, J., Cidre-Aranaz, F., Aynaud, M.-M., Orth, M. F., Knott, M. M. L., Mirabeau, O., Mazor, G., Varon, M., Hölting, T. L. B., Grossetête, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12071-2 · Cited by 66
JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer
Chen, B., Lai, J., Dai, D., Chen, R., Li, X., & Liao, N. (2019) · Aging · doi:10.18632/aging.102514 · Cited by 77
Clinical relevance of tumor microenvironment: immune cells, vessels, and mouse models
Katsuta, E., Rashid, O. M., & Takabe, K. (2020) · Human Cell · doi:10.1007/s13577-020-00380-4 · Cited by 73
“Comprehensive genomic data allow us to analyze not only gene expression, mutation [2–5], and expressions of micro-RNA [6, 7], but also infiltrating immune [8], other stromal cells in TME [9], and intra-tumoral clonality [10], through computational algorithms.”
BackgroundMa, C., Luo, H., Cao, J., Zheng, X., Zhang, J., Zhang, Y., & Fu, Z. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.571641 · Cited by 80
Feng, Y., Li, F., Yan, J., Guo, X., Wang, F., Shi, H., Du, J., Zhang, H., Gao, Y., Li, D., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120056 · Cited by 72
Rivas, E. I., Linares, J., Zwick, M., Gómez‐Llonín, A., Guiu, M., Labernadie, A., Badia-Ramentol, J., Lladó, A., Bardia, L., Pérez-Núñez, I., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32782-3 · Cited by 78
Li, Y., Jiang, M., Aye, L., Luo, L., Zhang, Y., Xu, F., Wei, Y., Peng, D., He, X., Gu, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45340-w · Cited by 71
“ESTIMATE method was used to calculate the tumor purity of bulk data 93 .”
MethodImmuno-transcriptomic profiling of extracranial pediatric solid malignancies
Brohl, A. S., Sindiri, S., Wei, J. S., Milewski, D., Chou, H.-C., Song, Y. K., Wen, X., Kumar, J., Reardon, H. V., Mudunuri, U. S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110047 · Cited by 77
“This expression data was used to predict enrichment scores of twenty-four immune signatures obtained from CIBERSORT (Newman et al., 2015) and ESTIMATE (Yoshihara et al., 2013) packages using singlesample GSEA (ssGSEA) from GenePattern (https://www.genepattern.org/modules/docs/ ssGSEAProjection/4).”
Gao, Y., Wang, H., Chen, S., An, R., Chu, Y., Li, G., Wang, Y., Xie, X., & Zhang, J. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03395-7 · Cited by 80
“Furthermore, to assess the relationship between m6A regulators and immunologic state in TME cells, we also estimated the ImmuneScore using the “estimate” R package [34] for 65,362 TME cells of CRC.”
MethodPeterziel, H., Jamaladdin, N., ElHarouni, D., Gerloff, X. F., Herter, S., Fiesel, P., Berker, Y., Blattner-Johnson, M., Schramm, K., Jones, B. C., et al. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00335-y · Cited by 79
“For immune microenvironment analysis, we used ESTIMATE with default parameters to measure overall immune in fi ltration (https:// bioinformatics.mdanderson.org/public-software/estimate/) 41 .”
Yang, Z., Liu, X., Xu, H., Teschendorff, A. E., Xu, L., Li, J., Fu, M., Liu, J., Zhou, H., Wang, Y., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06488-9 · Cited by 74
“ESTIMATEyieldsthe immunescoreandstromalscoreforeachsamplethatquanti fi esthelevelsof in fi ltration levels of immune and stromal cell based on its gene expression pro fi les 36 .”
Advances and applications in single-cell and spatial genomics
Wang, J., Ye, F., Chai, H., Jiang, Y., Wang, T., Ran, X., Xia, Q., Xu, Z., Fu, Y., Zhang, G., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2770-x · Cited by 79
A ZEB1/p53 signaling axis in stromal fibroblasts promotes mammary epithelial tumours
Fu, R., Han, C., Ni, T., Di, L., Liu, L., Lv, W., Bi, Y.-R., Jiang, N., He, Y., Li, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11278-7 · Cited by 75
Sun, J., Xie, T., Jamal, M., Tu, Z., Li, X., Wu, Y., Li, J., Zhang, Q., & Huang, X. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01183-1 · Cited by 75
Metadata
- Authors
- Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., Carter, S. L., Getz, G., Stemke-Hale, K., Mills, G. B., & Verhaak, R. G. W.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Southern California (US)
- Memorial Sloan Kettering Cancer Center (US)
- Broad Institute (US)
- Corresponding author
- Verhaak, Roel G.W.
- ORCID
- Venue
- Nature Communications
- Published
- 2013-10-11
- Volume
- 4
- Issue
- 1
- Pages
- 2612-2612
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3826632
- OpenAlex
- W2130430382
- Cited by
- 9,778
- References
- 63
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 1602 · 2023: 1755 · 2022: 1988 · 2021: 1316 · 2020: 683 · 2019: 223 · 2018: 121 · 2017: 93 · 2016: 53 · 2015: 39 · 2014: 20 · 2013: 2
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Communications (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (P50CA098258, U24CA143882, CA143883, U24CA143883, P30CA008748, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- tumor purity, tumor stroma, tumor-infiltrating immune cells, gene expression signatures, tumor microenvironment, DNA copy number, cancer transcriptomics
- MeSH terms
- Algorithms, Cell Separation, Female, Humans, Leukocytes, Neoplasms, Research Design, Sensitivity and Specificity, Software, Gene Library, Genome, Human, Stromal Cells, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, DNA Copy Number Variations, High-Throughput Nucleotide Sequencing, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.